IONS FY 2018 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$12B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$600M+16.6% YoY

Gross Profit

$598M99.7% margin

Operating Income

-$61M-10.2% margin

Net Income

$274M45.6% margin

EPS (Diluted)

$2.04

Cash Flow

Operating Cash Flow

$603M

Free Cash Flow

$585M

Stock-Based Comp.

$131M

Balance Sheet

Total Assets

$2.7B

Total Liabilities

$1.5B

Stockholders' Equity

$1.0B

Cash & Equivalents

$279M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$600M	$514M	+16.6%
Gross Profit	$598M	$514M	+16.3%
Operating Income	-$61M	$31M	-297.7%
Net Income	$274M	$346,000	+79015.9%